DCF — ALICE HYDE MEDICAL CENTER
Enterprise Value: $-70.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-70.5M
Enterprise Value
$-23.6M
PV of Cash Flows
$-46.9M
PV of Terminal Value
$-75.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $82.1M | $-3.7M | -4.0% | $-7.2M | $-6.5M |
| Year 2 | $84.5M | $-3.0M | -3.0% | $-6.5M | $-5.4M |
| Year 3 | $87.1M | $-2.2M | -2.0% | $-5.9M | $-4.4M |
| Year 4 | $89.7M | $-1.8M | -2.0% | $-5.6M | $-3.8M |
| Year 5 | $92.4M | $-1.6M | -2.0% | $-5.5M | $-3.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-70.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$79.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.04999999874500263
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5